KOHIMA, JUNE 30: Continuing with more COVID-19 recoveries than detection of fresh cases for the third consecutive day on Wednesday, Nagaland caseload surged to 25,239 with a report of 128 new cases, 165 recoveries and 2 deaths, a health official said.
“128 positive cases detected today are Kohima: 51, Dimapur: 25, Mokokchung: 23, Peren: 12, Phek: 5, Zunheboto: 4, Mon & Wokha: 3 each and Kiphire: 2”, said State Nodal Officer for Integrated Disease Surveillance Project, Dr Nyanthung Kikon in the daily COVID-19 bulletin.
He also said that 165 positive patients – Kohima: 45, Mon: 39, Mokokchung: 26, Dimapur: 24, Kiphire, Longleng & Peren: 7 each, Phek: 6 Zunheboto: 3 and Wokha: 1 – recovered during the day increasing the number of recovered patients to 22,699.
This has slightly improved the recovery rate from Tuesday’s 89.73% to 89.93%.
The caseload includes 1,341 active patients, of which, 152 are with mild symptoms, 33 are moderate on oxygen, 8 severe on oxygen, 3 critical in ICU without ventilator and 7 on ventilator, while 1,138 patients are asymptomatic, he said.
Demise of 2 positive patients at Dimapur district has increased the death toll in the State to 495, of which 14 patients had co-morbidities, he said.
Altogether 704 COVID-19 patients have migrated to other States, he said.
So far, a total of 2,26,675 suspected COVID-19 samples have been tested in Nagaland. It includes 97,822 on RT-PCR, 61,732 on TrueNat, and 67,121 on Rapid Antigen Test, said Dr Kikon.
Nagaland administered a total of 4,96,026 doses of COVID-19 vaccines to 4,35,664 persons till Tuesday, said State Immunization Officer Dr Ritu Thurr.
Out of the total doses administered in the State, 60,103 are frontline workers, 15,799 are healthcare professionals, 1,50,275 are people above 45 years and 2,09,487 in the 18 to 44 years age group, he said.
A total of 60,362 beneficiaries have received the second dose of the vaccine completing the full course of vaccination. They comprise 28,944 frontline workers, 10,494 healthcare workers, 20,913 people above 45 years and 11 in the 18 to 44 years age group, said Dr Thurr.
(Page News Service)